All In Biotech

Drug Trial Radar · NCT07285213

Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody

A Phase IIb, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of AZD5148 for Prevention of Recurrence of Clostridioides Difficile Infection in Individuals 18 Years of Age and Above

Last checked: Nov 19, 2026Latest source record: Nov 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 230 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

230

Planned (sponsor's estimate)

Start

Dec 10, 2025

Primary completion

Apr 20, 2027

Study completion Jan 18, 2028

Sponsor

Lead sponsor
AstraZenecaAstraZeneca (AZN)
Sponsor type
Industry
First posted
Dec 16, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Prevention
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the efficacy and safety of AZD5148 for prevention of recurrence of Clostridioides difficile infection in Individuals 18 years of age and above.

Conditions

  • Clostridioides Difficile Infection

Interventions

  • AZD5148Drug

    Participants will receive a single dose A of AZD5148 administered via either intramuscular injection or intravenous push.

  • PlaceboOther

    Participants will receive a single dose of placebo (0.9% (w/v) sodium chloride for injection) administered via either intramuscular injection or intravenous push.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. First occurrence of recurrence of C difficile infectionTime frame: Day 1 through day 91

Locations

117 sites in 14 countries. Site status is shown where the registry gives one.

  • Research Site

    Phoenix, Arizona · Withdrawn

  • Research Site

    Chula Vista, California · Withdrawn

  • Research Site

    Sacramento, California · Recruiting

  • Research Site

    Torrance, California · Recruiting

  • Research Site

    Hamden, Connecticut · Recruiting

  • Research Site

    Gainesville, Florida · Withdrawn

  • Research Site

    Hialeah, Florida · Recruiting

  • Research Site

    Homestead, Florida · Recruiting

  • Research Site

    Jacksonville, Florida · Recruiting

  • Research Site

    Miami Lakes, Florida · Withdrawn

  • Research Site

    Miramar, Florida · Withdrawn

  • Research Site

    Port Orange, Florida · Withdrawn

  • Research Site

    Tamarac, Florida · Withdrawn

  • Research Site

    Tampa, Florida · Withdrawn

  • Research Site

    Athens, Georgia · Recruiting

  • Research Site

    Atlanta, Georgia · Recruiting

  • Research Site

    Idaho Falls, Idaho · Recruiting

  • Research Site

    Burr Ridge, Illinois · Recruiting

  • Research Site

    Lexington, Kentucky · Withdrawn

  • Research Site

    Louisville, Kentucky · Recruiting

  • Research Site

    New Orleans, Louisiana · Recruiting

  • Research Site

    Glen Burnie, Maryland · Recruiting

  • Research Site

    Potomac, Maryland · Recruiting

  • Research Site

    Boston, Massachusetts · Recruiting

  • Research Site

    Boston, Massachusetts · Recruiting

  • Research Site

    Detroit, Michigan · Recruiting

  • Research Site

    Royal Oak, Michigan · Recruiting

  • Research Site

    Columbia, Missouri · Recruiting

  • Research Site

    Kansas City, Missouri · Recruiting

  • Research Site

    St Louis, Missouri · Recruiting

  • Research Site

    Union City, New Jersey · Recruiting

  • Research Site

    Hartsdale, New York · Withdrawn

  • Research Site

    Inwood, New York · Withdrawn

  • Research Site

    The Bronx, New York · Withdrawn

  • Research Site

    Salisbury, North Carolina · Recruiting

  • Research Site

    Winston-Salem, North Carolina · Recruiting

  • Research Site

    Pittsburgh, Pennsylvania · Withdrawn

  • Research Site

    Johnson City, Tennessee · Recruiting

  • Research Site

    Charlottesville, Virginia · Recruiting

  • Research Site

    Lynchburg, Virginia · Recruiting

Showing 40 of 117 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.